305 related articles for article (PubMed ID: 17303635)
21. Knock-in gain-of-function sodium channel mutation prolongs atrial action potentials and alters atrial vulnerability.
Blana A; Kaese S; Fortmüller L; Laakmann S; Damke D; van Bragt K; Eckstein J; Piccini I; Kirchhefer U; Nattel S; Breithardt G; Carmeliet P; Carmeliet E; Schotten U; Verheule S; Kirchhof P; Fabritz L
Heart Rhythm; 2010 Dec; 7(12):1862-9. PubMed ID: 20728579
[TBL] [Abstract][Full Text] [Related]
22. Reduction of dispersion of repolarization and prolongation of postrepolarization refractoriness explain the antiarrhythmic effects of quinidine in a model of short QT syndrome.
Milberg P; Tegelkamp R; Osada N; Schimpf R; Wolpert C; Breithardt G; Borggrefe M; Eckardt L
J Cardiovasc Electrophysiol; 2007 Jun; 18(6):658-64. PubMed ID: 17521304
[TBL] [Abstract][Full Text] [Related]
23. Empirical correlation of triggered activity and spatial and temporal re-entrant substrates with arrhythmogenicity in a murine model for Jervell and Lange-Nielsen syndrome.
Hothi SS; Thomas G; Killeen MJ; Grace AA; Huang CL
Pflugers Arch; 2009 Sep; 458(5):819-35. PubMed ID: 19430811
[TBL] [Abstract][Full Text] [Related]
24. Mechanisms of ventricular arrhythmogenesis in mice following targeted disruption of KCNE1 modelling long QT syndrome 5.
Thomas G; Killeen MJ; Gurung IS; Hakim P; Balasubramaniam R; Goddard CA; Grace AA; Huang CL
J Physiol; 2007 Jan; 578(Pt 1):99-114. PubMed ID: 17095567
[TBL] [Abstract][Full Text] [Related]
25. Differential effects of quinidine, flecainide, and cibenzoline on anisotropic conduction in the isolated porcine heart.
Lacroix D; Delfaut P; Adamantidis M; Cardinal R; Klug D; Kacet S; Dupuis B
J Cardiovasc Electrophysiol; 1998 Jan; 9(1):55-69. PubMed ID: 9475578
[TBL] [Abstract][Full Text] [Related]
26. Arrhythmic substrate, slowed propagation and increased dispersion in conduction direction in the right ventricular outflow tract of murine Scn5a+/- hearts.
Zhang Y; Guzadhur L; Jeevaratnam K; Salvage SC; Matthews GD; Lammers WJ; Lei M; Huang CL; Fraser JA
Acta Physiol (Oxf); 2014 Aug; 211(4):559-73. PubMed ID: 24913289
[TBL] [Abstract][Full Text] [Related]
27. Atrial arrhythmogenicity in aged Scn5a+/DeltaKPQ mice modeling long QT type 3 syndrome and its relationship to Na+ channel expression and cardiac conduction.
Guzadhur L; Pearcey SM; Duehmke RM; Jeevaratnam K; Hohmann AF; Zhang Y; Grace AA; Lei M; Huang CL
Pflugers Arch; 2010 Aug; 460(3):593-601. PubMed ID: 20552221
[TBL] [Abstract][Full Text] [Related]
28. Mannitol and hyponatremia regulate cardiac ventricular conduction in the context of sodium channel loss of function.
Blair GA; Wu X; Bain C; Warren M; Hoeker GS; Poelzing S
Am J Physiol Heart Circ Physiol; 2024 Mar; 326(3):H724-H734. PubMed ID: 38214908
[TBL] [Abstract][Full Text] [Related]
29. Ionic and cellular mechanisms underlying the development of acquired Brugada syndrome in patients treated with antidepressants.
Minoura Y; Di Diego JM; Barajas-MartÃnez H; Zygmunt AC; Hu D; Sicouri S; Antzelevitch C
J Cardiovasc Electrophysiol; 2012 Apr; 23(4):423-32. PubMed ID: 22034916
[TBL] [Abstract][Full Text] [Related]
30. Effect of pacing and mexiletine on dispersion of repolarisation and arrhythmias in DeltaKPQ SCN5A (long QT3) mice.
Fabritz L; Kirchhof P; Franz MR; Nuyens D; Rossenbacker T; Ottenhof A; Haverkamp W; Breithardt G; Carmeliet E; Carmeliet P
Cardiovasc Res; 2003 Mar; 57(4):1085-93. PubMed ID: 12650887
[TBL] [Abstract][Full Text] [Related]
31. Overexpression of SCN5A in mouse heart mimics human syndrome of enhanced atrioventricular nodal conduction.
Liu GX; Remme CA; Boukens BJ; Belardinelli L; Rajamani S
Heart Rhythm; 2015 May; 12(5):1036-45. PubMed ID: 25623181
[TBL] [Abstract][Full Text] [Related]
32. Gating-dependent mechanisms for flecainide action in SCN5A-linked arrhythmia syndromes.
Viswanathan PC; Bezzina CR; George AL; Roden DM; Wilde AA; Balser JR
Circulation; 2001 Sep; 104(10):1200-5. PubMed ID: 11535580
[TBL] [Abstract][Full Text] [Related]
33. Cellular basis for the Brugada syndrome and other mechanisms of arrhythmogenesis associated with ST-segment elevation.
Yan GX; Antzelevitch C
Circulation; 1999 Oct; 100(15):1660-6. PubMed ID: 10517739
[TBL] [Abstract][Full Text] [Related]
34. Separation of early afterdepolarizations from arrhythmogenic substrate in the isolated perfused hypokalaemic murine heart through modifiers of calcium homeostasis.
Killeen MJ; Gurung IS; Thomas G; Stokoe KS; Grace AA; Huang CL
Acta Physiol (Oxf); 2007 Sep; 191(1):43-58. PubMed ID: 17524066
[TBL] [Abstract][Full Text] [Related]
35. Transient alterations in transmural repolarization gradients and arrhythmogenicity in hypokalaemic Langendorff-perfused murine hearts.
Sabir IN; Killeen MJ; Goddard CA; Thomas G; Gray S; Grace AA; Huang CL
J Physiol; 2007 May; 581(Pt 1):277-89. PubMed ID: 17331992
[TBL] [Abstract][Full Text] [Related]
36. Altered re-excitation thresholds and conduction of extrasystolic action potentials contribute to arrhythmogenicity in murine models of long QT syndrome.
Duehmke RM; Pearcey S; Stefaniak JD; Guzadhur L; Jeevaratnam K; Costopoulos C; Pedersen TH; Grace AA; Huang CL
Acta Physiol (Oxf); 2012 Nov; 206(3):164-77. PubMed ID: 22510251
[TBL] [Abstract][Full Text] [Related]
37. Effects of Na+ channel blockers on extrasystolic stimulation-evoked changes in ventricular conduction and repolarization.
Osadchii OE
J Cardiovasc Pharmacol; 2014 Mar; 63(3):240-51. PubMed ID: 24220314
[TBL] [Abstract][Full Text] [Related]
38. A quantitative analysis of the effect of cycle length on arrhythmogenicity in hypokalaemic Langendorff-perfused murine hearts.
Sabir IN; Fraser JA; Cass TR; Grace AA; Huang CL
Pflugers Arch; 2007 Sep; 454(6):925-36. PubMed ID: 17437126
[TBL] [Abstract][Full Text] [Related]
39. Arrhythmogenic drugs can amplify spatial heterogeneities in the electrical restitution in perfused guinea-pig heart: An evidence from assessments of monophasic action potential durations and JT intervals.
Osadchii OE
PLoS One; 2018; 13(1):e0191514. PubMed ID: 29352276
[TBL] [Abstract][Full Text] [Related]
40. Transmural dispersion of repolarization and arrhythmogenicity: the Brugada syndrome versus the long QT syndrome.
Antzelevitch C; Yan GX; Shimizu W
J Electrocardiol; 1999; 32 Suppl():158-65. PubMed ID: 10688320
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
